A GMP logo or an undated claim is not enough to qualify a peptide supply chain. Useful evidence identifies the legal manufacturer, physical site, regulated activity, material scope, issuing authority and relevant dates. Each field must match the product being quoted.
ICH Q7 is a primary framework for GMP for active pharmaceutical ingredients. It explains quality-management expectations, but it does not certify a supplier. For European Union records, buyers can also search the official EudraGMDP database.
Define the required scope first
Start with the intended use and regulatory role of the material. A research reagent, an API starting material and an API for a regulated application do not create the same evidence requirement. The buyer's quality and regulatory teams should define the required status before price comparison.
Then map the proposed supply chain. Record the seller, legal manufacturer, manufacturing site, testing site, release site and any broker or distributor. A certificate belonging to one participant cannot silently be applied to another.
Fields to match on GMP evidence
| Field | Buyer check | Common mismatch |
|---|---|---|
| Legal entity | Match the registered name to the quoted manufacturer | Trading name or unrelated group company |
| Site address | Match the physical site performing the stated operation | Head office shown instead of manufacturing site |
| Activity | Confirm manufacture, testing, packaging, import or release as applicable | Warehouse scope presented as manufacturing scope |
| Material scope | Check whether the record covers the relevant API or category | Unrelated dosage form or product family |
| Authority and reference | Identify issuer, record number and official verification route | Private badge without an issuing basis |
| Dates and status | Review inspection, issue, validity or supersession context | Expired or superseded document |
Check official records in the correct jurisdiction
For evidence represented as an EU GMP certificate or non-compliance statement, search EudraGMDP using the legal name, site and record details. Compare the database result with the supplied copy rather than treating a matching company name as sufficient.
An absent EudraGMDP result does not prove that a facility has no relevant status anywhere. The database has a defined European scope. For another jurisdiction, identify the competent authority and its official verification channel, then retain the search date and result in the vendor file.
Use ICH Q7 to structure due diligence
ICH Q7 covers quality management, personnel, buildings, equipment, documentation, materials management, production, packaging and labelling, storage, laboratory controls, validation, change control, rejection and reuse, complaints and recalls, contract operations and distribution. A buyer can use those topics to structure a questionnaire or audit plan.
The guideline is not a substitute for product-specific assessment. Decide which sections apply to the proposed operation and request evidence proportionate to the intended use and risk.
Keep site evidence separate from batch evidence
A valid site record does not establish the identity, purity or suitability of a particular lot. Review the quoted specification, allocated-lot CoA and other available batch documents separately. Confirm who owns deviations, changes, complaints, recalls and document retention in the applicable agreement or purchase terms.
Qualification red flags
- The document names a different legal entity or address from the quoted manufacturer.
- The scope covers testing, storage or packaging but the supplier claims it proves manufacture.
- Dates, certificate number or issuing authority are missing or cannot be reconciled.
- A private audit badge is presented as a regulator-issued GMP certificate.
- The supplier will not identify the actual manufacturing site before approval.
- A generic certificate is used instead of answering which evidence applies to the offered material.
Record the qualification decision
- State the required regulatory and quality scope.
- Identify each legal entity and physical site in the proposed chain.
- Save the supplied document and official search result with access dates.
- List scope matches, mismatches and unresolved questions.
- Approve, conditionally approve or reject the source under the buyer's quality system.
- Set a review trigger for expiry, material change or a new manufacturing site.
Dr. Peptides does not make a universal GMP claim for every catalog item. Product specification, manufacturing scope, available batch documents and destination-specific delivery options are confirmed with each quote.
Official references
- ICH Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients.
- EudraGMDP GMP compliance search, European Medicines Agency system.
Frequently Asked Questions
Does ICH Q7 certify a peptide supplier?
No. ICH Q7 is a guideline for GMP for active pharmaceutical ingredients. It does not issue certificates or prove that a named company or facility complies with the guideline.
Does one GMP record cover every site and product?
No. GMP evidence has a defined legal entity, manufacturing site, activity, material scope and validity context. Buyers should match all of those fields to the proposed supply chain.
Can EudraGMDP verify every manufacturer worldwide?
No. EudraGMDP is an official European Union database for records within its system. It is valuable evidence for that scope, but it is not a universal registry for every jurisdiction or manufacturing activity.
Can a Certificate of Analysis replace GMP evidence?
No. A CoA reports batch results against stated specifications. GMP evidence concerns the quality system and authorized or inspected activities at a site. Buyers may need both, depending on the intended use.
What GMP status can Dr. Peptides confirm?
No sitewide GMP status is asserted here. The quotation should identify the offered material, manufacturing scope and available evidence for the proposed product and lot.